Abstract:Gene dosage variations occur in many diseases. In cancer, deletions and copy number increases contribute to alterations in the expression of tumour-suppressor genes and oncogenes, respectively. Developmental abnormalities, such as Down, Prader Willi, Angelman and Cri du Chat syndromes, result from gain or loss of one copy of a chromosome or chromosomal region. Thus, detection and mapping of copy number abnormalities provide an approach for associating aberrations with disease phenotype and for localizing critical genes. Comparative genomic hybridization3(CGH) was developed for genome-wide analysis of DNA sequence copy number in a single experiment. In CGH, differentially labelled total genomic DNA from a 'test' and a 'reference' cell population are cohybridized to normal metaphase chromosomes, using blocking DNA to suppress signals from repetitive sequences. The resulting ratio of the fluorescence intensities at a location on the 'cytogenetic map', provided by the chromosomes, is approximately proportional to the ratio of the copy numbers of the corresponding DNA sequences in the test and reference genomes. CGH has been broadly applied to human and mouse malignancies. The use of metaphase chromosomes, however, limits detection of events involving small regions (of less than 20 Mb) of the genome, resolution of closely spaced aberrations and linking ratio changes to genomic/genetic markers. Therefore, more laborious locus-by-locus techniques have been required for higher resolution studies2,3,4,5. Hybridization to an array of mapped sequences instead of metaphase chromosomes could overcome the limitations of conventional CGH (ref. 6) if adequate performance could be achieved. Copy number would be related to the test/reference fluorescence ratio on the array targets, and genomic resolution could be determined by the map distance between the targets, or by the length of the cloned DNA segments. We describe here our implementation of array CGH. We demonstrate its ability to measure copy number with high precision in the human genome, and to analyse clinical specimens by obtaining new information on chromosome 20 aberrations in breast cancer.

Standardization and Diversification of Copy Number Microarray Testing for Clinical Diagnostics—Implications of the Cross-Platform/Algorithm Study on Clinical Diagnostic Chromosomal Microarray Analysis

Accuracy Of Cnv Detection From Gwas Data

Chromosomal Microarray Analysis in Fetuses with Congenital Anomalies of the Kidney and Urinary Tract: A Prospective Cohort Study and Meta‐analysis

Oligonucleotide Microarrays for Clinical Diagnosis of Copy Number Variation

Clinical Application of Chromosome Microarray Analysis in Han Chinese Children with Neurodevelopmental Disorders

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

Abnormal Chromosomes Identification Using Chromosomal Microarray

Development Of A Focused Oligonucleotide-Array Comparative Genomic Hybridization Chip For Clinical Diagnosis Of Genomic Imbalance

Comparative Benchmarking of Optical Genome Mapping and Chromosomal Microarray Reveals High Technological Concordance in CNV Identification and Additional Structural Variant Refinement

Performance Assessment of Copy Number Microarray Platforms Using a Spike-in Experiment.

[The Diagnostic Value of Chromosome Microarray Analysis Technique in the Genetic Causes of Children with Intellectual Disability or Global Developmental Delay].

Clinical implementation of whole-genome array CGH as a first-tier test in 5080 pre and postnatal cases

Clinical impact of copy number variation analysis using high-resolution microarray technologies: advantages, limitations and concerns

Accurate and Sensitive Single-Cell-level Detection of Copy Number Variations by Micro-Channel Multiple Displacement Amplification (Μcmda).

Clinically significant findings in a decade‐long retrospective study of prenatal chromosomal microarray testing

Integrated analysis of copy number alteration and RNA expression profiles of cancer using a high-resolution whole-genome oligonucleotide array

Low-Pass Genome Sequencing: Validation and Diagnostic Utility from 409 Clinical Cases of Low-Pass Genome Sequencing for the Detection of Copy Number Variants to Replace Constitutional Microarray

Density Matters: Comparison of Array Platforms for Detection of Copy-Number Variation and Copy-Neutral Abnormalities.

A Single Cell Level Based Method For Copy Number Variation Analysis By Low Coverage Massively Parallel Sequencing

Genome-wide analysis of DNA copy-number changes using cDNA microarrays

Cancer Sample Analysis Utilizing Single-Nucleotide Polymorphism Array and Array Comparative Genomic Hybridization